MCOVBS Stock Overview
Provides healthcare and diagnostic services in Poland, Sweden, and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 4/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
Medicover AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr132.80 |
52 Week High | kr187.20 |
52 Week Low | kr132.80 |
Beta | 1.45 |
1 Month Change | -29.06% |
3 Month Change | -29.06% |
1 Year Change | n/a |
3 Year Change | -42.64% |
5 Year Change | 62.75% |
Change since IPO | 117.70% |
Recent News & Updates
Recent updates
Shareholder Returns
MCOVBS | GB Healthcare | GB Market | |
---|---|---|---|
7D | 0% | 2.7% | 1.3% |
1Y | n/a | -28.6% | 6.1% |
Return vs Industry: Insufficient data to determine how MCOVBS performed against the UK Healthcare industry.
Return vs Market: Insufficient data to determine how MCOVBS performed against the UK Market.
Price Volatility
MCOVBS volatility | |
---|---|
MCOVBS Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 7.4% |
Market Average Movement | 4.9% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: MCOVBS's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine MCOVBS's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 45,316 | Fredrik Rågmark | www.medicover.com |
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company’s Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology.
Medicover AB (publ) Fundamentals Summary
MCOVBS fundamental statistics | |
---|---|
Market cap | kr29.45b |
Earnings (TTM) | kr259.16m |
Revenue (TTM) | kr21.22b |
113.1x
P/E Ratio1.4x
P/S RatioIs MCOVBS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MCOVBS income statement (TTM) | |
---|---|
Revenue | €1.83b |
Cost of Revenue | €1.45b |
Gross Profit | €374.20m |
Other Expenses | €351.90m |
Earnings | €22.30m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 25, 2024
Earnings per share (EPS) | 0.15 |
Gross Margin | 20.49% |
Net Profit Margin | 1.22% |
Debt/Equity Ratio | 112.3% |
How did MCOVBS perform over the long term?
See historical performance and comparison